MarketCap
Facebook
X
TelegramAnnual report 2022
added 12-21-2024
Genetron Holdings Limited EV - Enterprise Value 2011-2025 | GTH
Annual EV - Enterprise Value Genetron Holdings Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 251 M | 1.21 B | 566 M | 2.46 B | 1.31 B | 1.18 B | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.46 B | 251 M | 1.16 B |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
223 M | $ 16.64 | -1.95 % | $ 99.4 M |  Israel |
 |
Exact Sciences Corporation
EXAS
|
12.2 B | $ 101.5 | - | $ 18.8 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 16.66 | 5.75 % | $ 179 M |  China |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
35.7 M | $ 1.57 | -3.4 % | $ 2 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
665 M | $ 38.42 | -0.54 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
DarioHealth Corp.
DRIO
|
6.61 M | $ 11.98 | 0.76 % | $ 340 M | Israel |
 |
DexCom
DXCM
|
52.4 B | $ 65.76 | -1.79 % | $ 25.4 B | USA |
 |
Danaher Corporation
DHR
|
150 B | $ 226.02 | -0.21 % | $ 165 B | USA |
 |
Fulgent Genetics
FLGT
|
502 M | $ 26.95 | -0.7 % | $ 815 M | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
644 M | $ 19.75 | -3.94 % | $ 1.06 B | USA |
 |
Celcuity
CELC
|
506 M | $ 103.17 | -1.98 % | $ 4.07 B | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
1.5 M | $ 3.37 | -5.86 % | $ 107 K | USA |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 0.31 | -9.72 % | $ 9.1 M | USA |
 |
IQVIA Holdings
IQV
|
54.8 B | $ 222.26 | 0.02 % | $ 40.3 B | USA |
 |
Guardant Health
GH
|
6.94 B | $ 103.49 | 1.39 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
15.3 B | $ 134.29 | -0.43 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
12.4 B | $ 196.54 | 1.84 % | $ 10.1 B | USA |
 |
Quotient Limited
QTNT
|
393 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
18.5 B | $ 183.1 | 0.32 % | $ 20.3 B | USA |
|
Biodesix
BDSX
|
142 M | $ 7.64 | -2.74 % | $ 991 M | USA |
 |
Mettler-Toledo International
MTD
|
33.2 B | $ 1 407.75 | 0.99 % | $ 29.9 B | Schweiz |
 |
Myriad Genetics
MYGN
|
1.2 B | $ 6.97 | -3.33 % | $ 631 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
29.9 B | $ 260.62 | -1.35 % | $ 21.9 B | USA |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 182.8 | -2.03 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
39.1 B | $ 699.0 | -0.74 % | $ 57.6 B | USA |
 |
NeoGenomics
NEO
|
1.9 B | $ 12.06 | 1.73 % | $ 1.53 B | USA |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 6.79 | -1.09 % | $ 1.47 B | USA |
 |
Lantheus Holdings
LNTH
|
6.44 B | $ 67.14 | 0.78 % | $ 4.65 B | USA |
 |
Agilent Technologies
A
|
45.8 B | $ 140.44 | 0.56 % | $ 42.7 B | USA |
 |
Biomerica
BMRA
|
6.63 M | $ 2.43 | -5.89 % | $ 5.58 M | USA |
 |
Bioventus
BVS
|
904 M | $ 7.53 | -0.26 % | $ 472 M | USA |
 |
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | Israel |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
Pacific Biosciences of California
PACB
|
2.28 B | $ 2.11 | -0.47 % | $ 535 M | USA |